[HBV infection: Screening and treatment for oncology patients].

This article proposes an overview on screening strategies and antiviral treatment recommendations for oncology patients. We have learned in hematology that reactivations are commun with rituximab and prophylactic treatment is recommanded for any patient who has been in contact with the virus. The risk appears to be lower with cytotoxics but has been far less studied. The recommandations are not formally consensual and upcoming studies will help to establish clearer practice guidelines.
PMID: 29066086 [PubMed - as supplied by publisher]

Source: Bulletin du Cancer - October 21, 2017 Category: Cancer & Oncology Authors: Jaillais A, Herber-Mayne A, D'Alteroche L, Landau A, Merrouche Y, Vignot S Tags: Bull Cancer Source Type: research